Bokf Na Buys 158 Shares of Agilent Technologies Inc (A)

Share on StockTwits

Bokf Na boosted its stake in shares of Agilent Technologies Inc (NYSE:A) by 1.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,229 shares of the medical research company’s stock after acquiring an additional 158 shares during the quarter. Bokf Na’s holdings in Agilent Technologies were worth $757,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of A. Findlay Park Partners LLP acquired a new stake in Agilent Technologies during the 4th quarter worth approximately $246,229,000. Oregon Public Employees Retirement Fund lifted its position in Agilent Technologies by 6,563.5% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 2,338,299 shares of the medical research company’s stock worth $35,000 after acquiring an additional 2,303,208 shares during the period. Marshall Wace LLP lifted its position in Agilent Technologies by 170.0% during the 3rd quarter. Marshall Wace LLP now owns 2,649,502 shares of the medical research company’s stock worth $186,896,000 after acquiring an additional 1,668,360 shares during the period. Point72 Asset Management L.P. lifted its position in Agilent Technologies by 1,375.4% during the 3rd quarter. Point72 Asset Management L.P. now owns 1,504,860 shares of the medical research company’s stock worth $106,153,000 after acquiring an additional 1,402,860 shares during the period. Finally, Pendal Group Ltd lifted its position in Agilent Technologies by 17,076.7% during the 4th quarter. Pendal Group Ltd now owns 1,227,965 shares of the medical research company’s stock worth $71,925,000 after acquiring an additional 1,220,816 shares during the period.

In related news, VP Rodney Gonsalves sold 6,155 shares of the firm’s stock in a transaction that occurred on Wednesday, March 6th. The stock was sold at an average price of $79.79, for a total value of $491,107.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Michael R. Mcmullen sold 17,491 shares of the firm’s stock in a transaction that occurred on Wednesday, January 30th. The shares were sold at an average price of $75.00, for a total value of $1,311,825.00. Following the completion of the transaction, the chief executive officer now directly owns 456,430 shares of the company’s stock, valued at $34,232,250. The disclosure for this sale can be found here. Over the last three months, insiders have sold 74,171 shares of company stock valued at $5,764,185.

A number of analysts have weighed in on A shares. Morgan Stanley increased their price objective on Agilent Technologies from $86.00 to $89.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 20th. Alembic Global Advisors cut Agilent Technologies to a “hold” rating in a research report on Monday, December 31st. Needham & Company LLC started coverage on Agilent Technologies in a research report on Wednesday, January 2nd. They set a “buy” rating and a $77.00 price objective for the company. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $79.00 price objective for the company in a research report on Monday, January 21st. Finally, Deutsche Bank increased their target price on Agilent Technologies from $80.00 to $85.00 and gave the stock a “buy” rating in a research note on Tuesday, February 12th. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The company has an average rating of “Buy” and an average target price of $86.91.

Shares of A stock opened at $81.20 on Wednesday. The company has a market cap of $25.71 billion, a PE ratio of 28.02, a price-to-earnings-growth ratio of 2.25 and a beta of 1.38. Agilent Technologies Inc has a 12-month low of $60.42 and a 12-month high of $81.77. The company has a quick ratio of 2.79, a current ratio of 3.39 and a debt-to-equity ratio of 0.36.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, February 20th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.73 by $0.03. The business had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.27 billion. Agilent Technologies had a return on equity of 19.90% and a net margin of 22.86%. The company’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.66 EPS. On average, equities research analysts expect that Agilent Technologies Inc will post 3.06 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Bokf Na Buys 158 Shares of Agilent Technologies Inc (A)” was first posted by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.tickerreport.com/banking-finance/4234585/bokf-na-buys-158-shares-of-agilent-technologies-inc-a.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Recommended Story: What is the QQQ ETF?

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Ally Financial  PT Set at $33.00 by Oppenheimer
Ally Financial PT Set at $33.00 by Oppenheimer
First Majestic Silver  PT Set at $8.00 by HC Wainwright
First Majestic Silver PT Set at $8.00 by HC Wainwright
QUALCOMM  Given a $85.00 Price Target at Macquarie
QUALCOMM Given a $85.00 Price Target at Macquarie
Legal & General Group Plc Trims Holdings in HNI Corp
Legal & General Group Plc Trims Holdings in HNI Corp
Legal & General Group Plc Buys 52,309 Shares of Grupo Financiero Galicia S.A.
Legal & General Group Plc Buys 52,309 Shares of Grupo Financiero Galicia S.A.
Legal & General Group Plc Increases Holdings in Patterson Companies, Inc.
Legal & General Group Plc Increases Holdings in Patterson Companies, Inc.


© 2006-2019 Ticker Report